Newsletter | March 3, 2026

03.03.26 -- The Rise Of The Autonomous Pharma Plant

SPONSOR

How AI-Enabled Digital Validation Technologies Enable the Predictive Plant

As life sciences manufacturers advance digital maturity, validation data is evolving from a compliance artifact into a strategic asset. This CAI webinar explores how second-generation, AI-enabled Digital Validation Technologies transform document-centric validation into predictive lifecycle intelligence. Learn how integrated DVT platforms enable real-time asset visibility, proactive risk identification, and data-driven decision-making across facilities, supporting operations and a predictive plant model. Click here to learn more.

INDUSTRY INSIGHTS

Advance Long-Term Cell Kinetics With Integrated Fluid Handling

Examine how a novel setup enables uninterrupted long-term cell-based assays by combining CO₂ regulation and evaporation control to improve cell viability and data consistency for real-time analysis.

Winning Strategies For Oral Dosage Form Development And Manufacturing

Failure to identify a compound’s red flags early in development often manifests as program delays or failures. Discover how to avoid these setbacks through complete molecular characterization.

Dynamic Precision Weighing Challenges And Innovations

Effective precision weighing systems enable users to balance product throughput, center distance, and standard deviation. Explore key considerations in this technology's development and weighing methods.

FROM THE EDITOR

The Rise Of The Autonomous Pharma Plant

What does a production facility of the future look like? That’s exactly what Bayer management asked its team before planning began for the world’s most modern pharmaceutical facility, Solida 1.

INDUSTRY INSIGHTS CONTINUED

Inline Buffer Formulation: A Facility Operations Game Changer

Inline buffer formulation leverages real-time, precise buffer preparation throughout production, enabling agile, efficient, and scalable manufacturing processes that save time and resources.

High-Content Imaging Drives Protein Degraders From Hit To Lead

Uncover a cost-effective high-content immunofluorescence workflow using the Revvity Opera Phenix™ system to efficiently identify small molecule protein degraders with rich, multi-dimensional data.

5 Critical PUPSIT Considerations For Sponsors Targeting The EU Market

To ensure compliance with EU GMP Annex 1 guidelines and drug product approval, familiarize yourself with PUPSIT: how it works, why it’s needed, and strategies to maximize success.

Driving Robust Tech Transfer In Biologics: Computational Fluid Dynamics

Computational Fluid Dynamics simulation is essential for robust biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market.

Process Re-Design For Sustainability In Small Molecule Manufacturing

Review the optimization of the manufacturing process of a pharmaceutical intermediate, as well as how yield can be improved substantially via suitable reaction engineering.

A Closer Look At Inspection Systems In Tablet And Capsule Production

Walk through the rigorous inspection process pharmaceutical products undergo to ensure safety and quality, from granulated ingredients to packaging.

Fast-Track Innovation, Address CMC Challenges In Expedited Pathways

Learn to overcome solubility challenges and utilize flexible development strategies to transition innovative treatments from early-phase trials to commercialization while ensuring patient safety.

New Vs. Used Processing Equipment: A Cost Comparison

For pharmaceutical and chemical manufacturers, balancing budgets with operational needs is crucial. Find out how sourcing used equipment offers significant cost advantages over new.

Effective Environmental Monitoring And Control In Pharma Operations

A structured contamination control strategy uses the Plan, Do, Study, Act model, focusing on EMPQ, meticulous planning, trend analysis, and continuous improvement with CAPA and change control.

SPONSOR

The 4th Nasal Formulation & Delivery Summit is uniting formulation, delivery, and product development leaders to advance the development of safe, effective, and commercially viable intranasal therapies. Join 70+ experts from Eli Lilly, Bayer, Neurelis, Virpax Pharmaceuticals, Belhaven Biopharma, and more to explore real-world preclinical and clinical data, compare liquid and powder nasal approaches, and align on best practices for systemic and nose-to-brain delivery.

SOLUTIONS

Solid Form Services

Modern MES Software For Drug Manufacturing

Two Sites, One Standard Of Excellence

Don't Just Transform Once. Transform Continuously.

Multipurpose Aseptic Isolator For GMP Processing

Advancing Clean Manufacturing Through Contamination Control

Connect With Pharmaceutical Online: